153 related articles for article (PubMed ID: 12558963)
1. Dose-dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences.
Zafar KS; Siddiqui A; Sayeed I; Ahmad M; Salim S; Islam F
J Neurochem; 2003 Feb; 84(3):438-46. PubMed ID: 12558963
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of adenosine in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences.
Zafar KS; Siddiqui A; Sayeed I; Ahmad M; Saleem S; Islam F
J Chem Neuroanat; 2003 Oct; 26(2):143-51. PubMed ID: 14599664
[TBL] [Abstract][Full Text] [Related]
3. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
[TBL] [Abstract][Full Text] [Related]
4. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of methanolic extract of Garcinia indica fruits in 6-OHDA rat model of Parkinson's disease.
Antala BV; Patel MS; Bhuva SV; Gupta S; Rabadiya S; Lahkar M
Indian J Pharmacol; 2012; 44(6):683-7. PubMed ID: 23248394
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection by crocetin in a hemi-parkinsonian rat model.
Ahmad AS; Ansari MA; Ahmad M; Saleem S; Yousuf S; Hoda MN; Islam F
Pharmacol Biochem Behav; 2005 Aug; 81(4):805-13. PubMed ID: 16005057
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats.
Ahmad M; Saleem S; Ahmad AS; Ansari MA; Yousuf S; Hoda MN; Islam F
Hum Exp Toxicol; 2005 Mar; 24(3):137-47. PubMed ID: 15901053
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson's disease.
Ahmad M; Yousuf S; Khan MB; Ahmad AS; Saleem S; Hoda MN; Islam F
Hum Exp Toxicol; 2006 Jul; 25(7):361-8. PubMed ID: 16898164
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies.
Santamaría A; Salvatierra-Sánchez R; Vázquez-Román B; Santiago-López D; Villeda-Hernández J; Galván-Arzate S; Jiménez-Capdeville ME; Ali SF
J Neurochem; 2003 Jul; 86(2):479-88. PubMed ID: 12871589
[TBL] [Abstract][Full Text] [Related]
12. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
Youdim MB; Stephenson G; Ben Shachar D
Ann N Y Acad Sci; 2004 Mar; 1012():306-25. PubMed ID: 15105275
[TBL] [Abstract][Full Text] [Related]
13. Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism.
Roghani M; Niknam A; Jalali-Nadoushan MR; Kiasalari Z; Khalili M; Baluchnejadmojarad T
Brain Res Bull; 2010 Jul; 82(5-6):279-83. PubMed ID: 20558255
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents.
Tariq M; Khan HA; Al Moutaery K; Al Deeb S
Brain Res Bull; 2001 Jan; 54(1):77-82. PubMed ID: 11226716
[TBL] [Abstract][Full Text] [Related]
15. Selenium protects cerebral ischemia in rat brain mitochondria.
Ansari MA; Ahmad AS; Ahmad M; Salim S; Yousuf S; Ishrat T; Islam F
Biol Trace Elem Res; 2004 Oct; 101(1):73-86. PubMed ID: 15516704
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective Effects of Sulphated Agaran from Marine Alga Gracilaria cornea in Rat 6-Hydroxydopamine Parkinson's Disease Model: Behavioural, Neurochemical and Transcriptional Alterations.
Souza RB; Frota AF; Sousa RS; Cezario NA; Santos TB; Souza LM; Coura CO; Monteiro VS; Cristino Filho G; Vasconcelos SM; da Cunha RM; Aguiar LM; Benevides NM
Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):159-170. PubMed ID: 27612165
[TBL] [Abstract][Full Text] [Related]
17. Effects of WR1065 on 6-hydroxydopamine-induced motor imbalance: Possible involvement of oxidative stress and inflammatory cytokines.
Kheradmand A; Nayebi AM; Jorjani M; Khalifeh S; Haddadi R
Neurosci Lett; 2016 Aug; 627():7-12. PubMed ID: 27222379
[TBL] [Abstract][Full Text] [Related]
18. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
Nehru B; Verma R; Khanna P; Sharma SK
Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
[TBL] [Abstract][Full Text] [Related]
19. Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism.
Borah A; Mohanakumar KP
Brain Res; 2010 Jul; 1344():192-9. PubMed ID: 20470760
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
